Clinical study on treatment of chronic prostatitis complicated with Prostate Glioclones with urinary stone pill combined with Tylenol Hydrochloride Sustained Release Capsule
10.3969/j.issn.1005-1678.2017.10.022
- VernacularTitle:尿石通丸联合盐酸坦洛新缓释胶囊治疗慢性前列腺炎合并前列腺结石疗效研究
- Author:
Shui XU
1
Author Information
1. 浙江省兰溪市人民医院 泌尿外科
- Keywords:
urine stone pills;
tamsulosin hydrochloride sustained-release capsules;
chronic prostatitis;
prostate stones
- From:
Chinese Journal of Biochemical Pharmaceutics
2017;37(10):58-59
- CountryChina
- Language:Chinese
-
Abstract:
Objective To study the effect of urine stone pills combined with tamsulosin hydrochloride sustained-release capsules in the treatment of chronic prostatitis with prostatic calculi. Methods 76 patients with chronic prostatitis with prostate stones who had been hospitalized were treated as 76 patients in this study. A total of 38 patients in a single group were treated with tylosine hydrochloride sustained-release capsules. 38 patients in the combined group were treated with Urethomide Pill on the basis of a single group of patients. The chronic prostatitis symptom index (NIH-CPSI) Clinical efficacy, white blood cell levels in prostatic fluid and the incidence of adverse reactions. Results The total effective rate was 94.74 % in the combined group, which was significantly lower than that in the single group (76.32 %)(P<0.05); the NIH-CPSI and prostatic fluid in the combined group were significantly lower than those in the single group(P<0.05), the incidence of adverse reactions in a single group was 7.89 %, and there was no significant difference between the combined group(5.26 %). Conclusion The treatment of chronic prostatitis with prostatic calculi is significant and feasible.
